.png)
Female Sexual Dysfunction Treatment Market By Treatment Type - Global Industry Analysis And Forecast To 2027
Published On : April 2019 Pages : 155 Category: Pharma & Healthcare Report Code : HC043349
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Female Sexual Dysfunction Treatment Market By Treatment Type (Estrogen Therapy, Ospemifene (Osphena), Androgen Therapy and Flibanserin (Addyi) - Global Industry Analysis And Forecast To 2027
Industry Outlook
Determined, repetitive issues with the sexual response, orgasm, pain or desire that trouble the individual or strain the relationship with the partner are referred therapeutically as the sexual dysfunction. Numerous ladies experience issues with the sexual function sooner or later, and some experience issues for the duration of their lives. The female sexual dysfunction may happen at any life phase. It may happen just in certain sexual circumstances or in every sexual circumstance. Therefore, the Female Sexual Dysfunction Treatment Market is anticipated to expand and has tremendous scope during the forecast period. The global Female Sexual Dysfunction Treatment Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Drivers & Restrains
Factors driving the market are; increasing awareness regarding the sexual dysfunction, more development in the technology related to treatment, increasing utilization of the treatment for sexual dysfunction, increase in the number of cases related to the sexual dysfunction and few other factors. The factor affecting the growth of market is the lack of awareness and some social barriers.
Regional Insights
The North American region is leading the global Female Sexual Dysfunction Treatment Market due to technological development in the healthcare sector, more research & development activities in this region, increasing awareness amongst the population and few other factors.
Female Sexual Dysfunction Treatment Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Pfizer Inc.
- GlaxoSmithKline plc.
- Apricus Biosciences Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Female Sexual Dysfunction Treatment Market, By Treatment Type, Estimates and Forecast, 2017-2027 ($Million)
o Estrogen Therapy
o Ospemifene (Osphena)
o Androgen Therapy
o Flibanserin (Addyi)
o Female Sexual Dysfunction Treatment Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Pfizer Inc.
o GlaxoSmithKline plc.
o Apricus Biosciences Inc.
o Female Sexual Dysfunction Treatment Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Female Sexual Dysfunction Treatment Market, By Country
o U.S. Female Sexual Dysfunction Treatment Market
o Canada Female Sexual Dysfunction Treatment Market
o Mexico Female Sexual Dysfunction Treatment Market
o Europe
§ Europe Female Sexual Dysfunction Treatment Market, By Country
o Germany Female Sexual Dysfunction Treatment Market
o UK Female Sexual Dysfunction Treatment Market
o France Female Sexual Dysfunction Treatment Market
o Russia Female Sexual Dysfunction Treatment Market
o Italy Female Sexual Dysfunction Treatment Market
o Rest of Europe Female Sexual Dysfunction Treatment Market
o Asia-Pacific
§ Asia-Pacific Female Sexual Dysfunction Treatment Market, By Country
o China Female Sexual Dysfunction Treatment Market
o Japan Female Sexual Dysfunction Treatment Market
o South Korea Female Sexual Dysfunction Treatment Market
o India Female Sexual Dysfunction Treatment Market
o Southeast Asia Female Sexual Dysfunction Treatment Market
o Rest of Asia-Pacific Female Sexual Dysfunction Treatment Market
o South America
§ South America Female Sexual Dysfunction Treatment Market, By Country
o Brazil Female Sexual Dysfunction Treatment Market
o Argentina Female Sexual Dysfunction Treatment Market
o Columbia Female Sexual Dysfunction Treatment Market
o Rest of South America Female Sexual Dysfunction Treatment Market
o Middle East and Africa
§ Middle East and Africa Female Sexual Dysfunction Treatment Market, By Country
o Saudi Arabia Female Sexual Dysfunction Treatment Market
o UAE Female Sexual Dysfunction Treatment Market
o Egypt Female Sexual Dysfunction Treatment Market
o Nigeria Female Sexual Dysfunction Treatment Market
o South Africa Female Sexual Dysfunction Treatment Market
o Rest of MEA Female Sexual Dysfunction Treatment Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Female Sexual Dysfunction Treatment Market, By Treatment Type
5.1. Introduction
5.2. Global Female Sexual Dysfunction Treatment Revenue and Market Share by Treatment Type (2017-2027)
5.2.1. Global Female Sexual Dysfunction Treatment Revenue and Revenue Share by Treatment Type (2017-2027)
5.3. Estrogen Therapy
5.3.1. Global Estrogen Therapy Revenue and Growth Rate (2017-2027)
5.4. Ospemifene (Osphena)
5.4.1. Global Ospemifene (Osphena) Revenue and Growth Rate (2017-2027)
5.5. Androgen Therapy
5.5.1. Global Androgen Therapy Revenue and Growth Rate (2017-2027)
5.6. Flibanserin (Addyi)
5.6.1. Global Flibanserin (Addyi) Revenue and Growth Rate (2017-2027)
6. Female Sexual Dysfunction Treatment Market, By Region
6.1. Introduction
6.2. Global Female Sexual Dysfunction Treatment Revenue and Market Share by Regions
6.2.1. Global Female Sexual Dysfunction Treatment Revenue by Regions (2017-2027)
6.3. North America Female Sexual Dysfunction Treatment by Countries
6.3.1. North America Female Sexual Dysfunction Treatment Revenue and Growth Rate (2017-2027)
6.3.2. North America Female Sexual Dysfunction Treatment Revenue (Million USD) by Countries (2017-2027)
6.3.3. United States
6.3.3.1. United States Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.3.4. Canada
6.3.4.1. Canada Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.3.5. Mexico
6.3.5.1. Mexico Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.4. Europe Female Sexual Dysfunction Treatment by Countries
6.4.1. Europe Female Sexual Dysfunction Treatment Revenue and Growth Rate (2017-2027)
6.4.2. Europe Female Sexual Dysfunction Treatment Revenue (Million USD) by Countries (2017-2027)
6.4.3. Germany
6.4.3.1. Germany Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.4. France
6.4.4.1. France Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.5. UK
6.4.5.1. UK Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.6. Russia
6.4.6.1. Russia Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.7. Italy
6.4.7.1. Italy Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.8. Rest of Europe
6.4.8.1. Rest of Europe Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.5. Asia-Pacific Female Sexual Dysfunction Treatment by Countries
6.5.1. Asia-Pacific Female Sexual Dysfunction Treatment Revenue and Growth Rate (2017-2027)
6.5.2. Asia-Pacific Female Sexual Dysfunction Treatment Revenue (Million USD) by Countries (2017-2027)
6.5.3. China
6.5.3.1. China Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.4. Japan
6.5.4.1. Japan Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.5. Korea
6.5.5.1. Korea Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.6. India
6.5.6.1. India Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.7. Southeast Asia
6.5.7.1. Southeast Asia Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.8. Rest of Asia-Pacific
6.5.8.1. Rest of Asia-Pacific Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.6. South America Female Sexual Dysfunction Treatment by Countries
6.6.1. South America Female Sexual Dysfunction Treatment Revenue and Growth Rate (2017-2027)
6.6.2. South America Female Sexual Dysfunction Treatment Revenue (Million USD) by Countries (2017-2027)
6.6.3. Brazil
6.6.3.1. Brazil Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.4. Argentina
6.6.4.1. Argentina Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.5. Columbia
6.6.5.1. Columbia Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.6. Rest of South America
6.6.6.1. Rest of South America Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.7. Middle East and Africa Female Sexual Dysfunction Treatment by Countries
6.7.1. Middle East and Africa Female Sexual Dysfunction Treatment Revenue and Growth Rate (2017-2027)
6.7.2. Middle East and Africa Female Sexual Dysfunction Treatment Revenue (Million USD) by Countries (2017-2027)
6.7.3. Saudi Arabia
6.7.3.1. Saudi Arabia Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.4. United Arab Emirates
6.7.4.1. United Arab Emirates Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.5. Egypt
6.7.5.1. Egypt Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.6. Nigeria
6.7.6.1. Nigeria Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.7. South Africa
6.7.7.1. South Africa Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.8. Turkey
6.7.8.1. Turkey Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.9. Rest of Middle East and Africa
6.7.9.1. Rest of Middle East and Africa Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
7. Company Profiles
7.1. Pfizer Inc.
7.1.1. Business Overview
7.1.2. Service Portfolio
7.1.3. Strategic Developments
7.1.4. Financial Overview
7.2. GlaxoSmithKline plc.
7.2.1. Business Overview
7.2.2. Service Portfolio
7.2.3. Strategic Developments
7.2.4. Financial Overview
7.3. Apricus Biosciences Inc.
7.3.1. Business Overview
7.3.2. Service Portfolio
7.3.3. Strategic Developments
7.3.4. Financial Overview
8. Global Female Sexual Dysfunction Treatment Market Competition, by Manufacturer
8.1. Global Female Sexual Dysfunction Treatment Financial Overview by Manufacturer (2017-2017)
8.2. Global Female Sexual Dysfunction Treatment Price By Region (2017-2017)
8.3. Top 5 Female Sexual Dysfunction Treatment Manufacturer Market Share
8.4. Market Competition Trend
9. Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.1. Global Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Female Sexual Dysfunction Treatment Market Forecast by Regions (2017-2027)
9.2.1. North America Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.1.1. United States Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.1.2. Canada Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.1.3. Mexico Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.2. Europe Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.2.1. Germany Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.2.2. France Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.2.3. UK Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.2.4. Russia Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.2.5. Italy Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.3. Asia-Pacific Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.3.1. China Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.3.2. Japan Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.3.3. Korea Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.3.4. India Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.4. South America Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.4.1. Brazil Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.4.2. Argentina Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.4.3. Columbia Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.4.4. Rest of South America Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.5. Middle East and Africa Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.5.3. Egypt Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.5.4. Nigeria Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.5.5. South Africa Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.5.6. Turkey Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Female Sexual Dysfunction Treatment Market Forecast (2017-2027)
9.3. Female Sexual Dysfunction Treatment Market Forecast by Treatment Type (2017-2027)
9.3.1. Female Sexual Dysfunction Treatment Forecast by Treatment Type (2017-2027)
9.3.2. Female Sexual Dysfunction Treatment Market Share Forecast by Treatment Type (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Female Sexual Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Female Sexual Dysfunction Treatment Revenue and Revenue Share by Treatment Type (2017-2018)
Figure Global Estrogen Therapy Revenue and Growth Rate (2017-2018)
Figure Global Ospemifene (Osphena) Revenue and Growth Rate (2017-2018)
Figure Global Androgen Therapy Revenue and Growth Rate (2017-2018)
Figure Global Flibanserin (Addyi) Revenue and Growth Rate (2017-2018)
Table Global Female Sexual Dysfunction Treatment Revenue by Regions (2017-2018)
Figure North America Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure North America Female Sexual Dysfunction Treatment Revenue and Growth Rate (2017-2018)
Figure North America Female Sexual Dysfunction Treatment by Countries (2017-2018)
Figure North America Female Sexual Dysfunction Treatment Revenue (Million USD) by Countries (2017-2018)
Figure United States Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure United States Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Canada Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Mexico Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Europe Female Sexual Dysfunction Treatment Revenue and Growth Rate (2017-2018)
Figure Europe Female Sexual Dysfunction Treatment by Countries (2017-2018)
Figure Europe Female Sexual Dysfunction Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Germany Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Germany Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure France Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure UK Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Russia Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Italy Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Rest of Europe Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Asia-Pacific Female Sexual Dysfunction Treatment Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Female Sexual Dysfunction Treatment by Countries (2017-2018)
Figure Asia-Pacific Female Sexual Dysfunction Treatment Revenue (Million USD) by Countries (2017-2018)
Figure China Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure China Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Japan Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Korea Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure India Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Southeast Asia Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure South America Female Sexual Dysfunction Treatment Revenue and Growth Rate (2017-2018)
Figure South America Female Sexual Dysfunction Treatment by Countries (2017-2018)
Figure South America Female Sexual Dysfunction Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Brazil Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Argentina Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Columbia Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Rest of South America Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Middle East and Africa Female Sexual Dysfunction Treatment Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Female Sexual Dysfunction Treatment by Countries (2017-2018)
Figure Middle East and Africa Female Sexual Dysfunction Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Saudi Arabia Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure United Arab Emirates Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Egypt Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Nigeria Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure South Africa Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Turkey Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Female Sexual Dysfunction Treatment Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Table Pfizer Inc. Female Sexual Dysfunction Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GlaxoSmithKline plc. Female Sexual Dysfunction Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Apricus Biosciences Inc. Female Sexual Dysfunction Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Female Sexual Dysfunction Treatment Market Share by Manufacturer
Figure Global Female Sexual Dysfunction Treatment Revenue and Market Share by Manufacturer
Table Global Female Sexual Dysfunction Treatment Price by Region (2017-2017)
Figure Top 5 Female Sexual Dysfunction Treatment Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Female Sexual Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2018-2025)
Table Female Sexual Dysfunction Treatment Market Forecast by Regions (2018-2025)
Figure North America Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure United States Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Canada Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Mexico Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Europe Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Germany Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure France Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure UK Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Russia Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Italy Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Rest of Europe Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Asia-Pacific Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure China Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Japan Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Korea Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure India Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Southeast Asia Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure South America Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Brazil Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Argentina Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Columbia Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Rest of South America Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Middle East and Africa Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Saudi Arabia Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure United Arab Emirates Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Egypt Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Nigeria Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure South Africa Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Turkey Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Female Sexual Dysfunction Treatment Market Forecast (2018-2025)
Figure Global Female Sexual Dysfunction Treatment Forecast by Treatment Type (2018-2025)
Figure Global Female Sexual Dysfunction Treatment Market Share Forecast by Treatment Type (2018-2025)
Figure Global Female Sexual Dysfunction Treatment Forecast by Treatment Type (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|